Supplemental Tables 1 - 7 from Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

Supplemental Table 1:A. Characteristics of the antibodies used for immunohistochemical measures B.Clinical characteristics of the CIT cohort of patients. Supplemental Table 2: A .Gene expression related statistics in the CIT cohort. B. immunohistochemistry quickscore measures of SOX4 and IVL and prediction of the basaloid satus Supplemental Table 3: Gene signatures and pathways deregulation analysis in histological subtypes. Supplemental Table 4: DNA copy number aberrations related statistics in the CIT cohort. Supplemental Table 5: 139-gene centroids used for prediction of the CIT molecular subtypes. Supplemental Table 6: Molecular subtype prediction and survival data for each sample of the CIT and 8 validation datasets. Supplemental Table 7: Gene signatures and pathways enrichment analysis in molecular subtypes in the CIT cohort and 4 validation datasets.